drugset / Trial / NCT01909986

A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

NCT01909986

Phase 1 Completed 8 enrolled Ono Pharmaceutical Co., Ltd.
Non-randomizedSingle-groupOpen-label

Summary

This is a single dose mass balance study in healthy adult male volunteers to investigate the metabolism and excretion of \[14C\]-ONO-4053.

Timeline

Start
2013-10
Primary completion
2014-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-4053 Unknown Oral

Indications

No indication recorded.